152
152
Dec 18, 2013
12/13
by
BLOOMBERG
tv
eye 152
favorite 0
quote 0
cvs caremark reaffirmed its forecast this morning and offered a forecast and efforts -- in lines withates. a plan for $4 billion in share buyback next year. all time high in shares of cvs. ♪ >> this is "lunch money." we are also streaming live on bloomberg.com, your tablet, and smartphones. i am adam johnson. this is where the video is the story. president obama chooses an openly gay athlete as one of the was representative that the ceremonies in russia. russia has come under international pressure for anti- gay laws. for the first time in more than a decade, the president, vice president nor the first lady of the united states will attend. its first restaurant there tomorrow. the moscow location will send -- sell shake burgers for seven dollars, 50% higher than what it charges in new york and priceough -- triple the -- mcdonald's opened its first outlet, that opening from 30,000 people. he does women -- winners in last night's mega millions jackpot pair the gift shop in san jose carus sought -- california sold one of the tickets and the other was sold in atlanta. there were 20 ticket
cvs caremark reaffirmed its forecast this morning and offered a forecast and efforts -- in lines withates. a plan for $4 billion in share buyback next year. all time high in shares of cvs. ♪ >> this is "lunch money." we are also streaming live on bloomberg.com, your tablet, and smartphones. i am adam johnson. this is where the video is the story. president obama chooses an openly gay athlete as one of the was representative that the ceremonies in russia. russia has come under...
207
207
Dec 19, 2013
12/13
by
FBC
tv
eye 207
favorite 0
quote 0
nicole: taking a look at rite-aid, walgreen's, cvs caremark, raise their dividend yesterday and the stock a new high. rite-aid and walgreen's pulling back and rite-aid in a big way down 10%, talked-about the fact their revenue is under pressure because of generic competition and with that it is all about the margins and they had to lower their numbers for earnings per share. we are seeing that stock down 10% as they cut their estimates for, they had seen continued sales growth but in the drug part of the business prescription drugs generics are eating into the profits. adam: the effectiveness a spying allegations affect business around a world, boeing lost on one of the most coveted emerging-market defense contracts when the $4.5 billion contract was awarded. some analysts believe the reason for the break down in the decades-long negotiations was brazil's and ability to trust a u.s. company following the organizations of nsa spying on brazil's president lee shares of boeing to the hon news. lori: wells fargo on ben bernanke, the company's announcement, and spike opportunities now. first t
nicole: taking a look at rite-aid, walgreen's, cvs caremark, raise their dividend yesterday and the stock a new high. rite-aid and walgreen's pulling back and rite-aid in a big way down 10%, talked-about the fact their revenue is under pressure because of generic competition and with that it is all about the margins and they had to lower their numbers for earnings per share. we are seeing that stock down 10% as they cut their estimates for, they had seen continued sales growth but in the drug...
297
297
Dec 10, 2013
12/13
by
CNBC
tv
eye 297
favorite 0
quote 0
then cvs caremark and cardinal health moving higher after announcing a joint venture to create the largestperation in the united states. abbvie show 96% of patients in hepatitis c trial. gilead's hepatitis pill approved by fda, price came under fire from pharmacy benefit manager express scripts. abbivie to the upside and gilead to the downside. >> thanks very much. as stocks continue at or near record levels debate on if a major pullback looms. my next guest worried about the level of risk people are worried about taking, howard marks. billionaire investor from oaktree capital joining me on the floor of the exchange. welcome. >> nice to see you. >> we were talking about valuations in these markets. i wonder do you look at the market and see evidence of froth, a bubble or are equities still cheap? >> you're talking about equities. equities were in the dog house for 12 years. that's the longest time in my experience from 2000 to 2012. they've been picking up in '12 and '13. i think they went from cryingly cheap to roughly fairly valued now. i don't think they're overvalued but debate on both
then cvs caremark and cardinal health moving higher after announcing a joint venture to create the largestperation in the united states. abbvie show 96% of patients in hepatitis c trial. gilead's hepatitis pill approved by fda, price came under fire from pharmacy benefit manager express scripts. abbivie to the upside and gilead to the downside. >> thanks very much. as stocks continue at or near record levels debate on if a major pullback looms. my next guest worried about the level of...
239
239
Dec 18, 2013
12/13
by
CNBC
tv
eye 239
favorite 0
quote 0
like at cvs caremark.allocation. $4 billion buyback in 2014. a new $6 billion buyback plan over an unspecified multi-year period. that takes it to $1.10 a share. it was inactive in the premarket. >> what's interesting is they say this comes from an understanding of obamacare. >> then take a look at apple. various headlines here today. china daily quoting the ceo of china mobile saying there is no deal, in fact, between china mobile and apple yet, even though the journal, jon fortt, when they wrote about that would-be deal a couple of weeks ago said an announcement would be coming about now. >> not only that but i see china mobile subsidiary has a change up that has to do with preorders. the page looks legit to me. i checked it out multiple different ways. i can get to it from china mobile's home page. so something fishy is going ton he -- on here. they have pages up and down indicating the 5s will be on sale soon. it's been up for several hours. >> you also have jabil with a negative forecast, which does s
like at cvs caremark.allocation. $4 billion buyback in 2014. a new $6 billion buyback plan over an unspecified multi-year period. that takes it to $1.10 a share. it was inactive in the premarket. >> what's interesting is they say this comes from an understanding of obamacare. >> then take a look at apple. various headlines here today. china daily quoting the ceo of china mobile saying there is no deal, in fact, between china mobile and apple yet, even though the journal, jon fortt,...
206
206
Dec 10, 2013
12/13
by
CNBC
tv
eye 206
favorite 0
quote 0
. >> so cvs, caremark, and cardinal health are forming a joint venture to create the largest genericrately, extending a three-year agreement, a deal for cardinal health to distribute cvs pharmaceutical products. both stocks are higher on this news sharply. so again, cah and cvs both to the upside. over to you. >> all right, dom, thank you. >>> the s&p has outperformed europe's broader markets, what does goldman sachs see in the year ahead? they offer the outlook for 2014. >>> also ahead, kenneth jacobs interview. how might the volcker rule impact his firm? i'm beth... and i'm michelle. and we own the paper cottage. it's a stationery and gifts store. anything we purchase for the paper cottage goes on our ink card. so you can manage your business expenses and access them online instantly with the game changing app from ink. we didn't get into business to spend time managing receipts, that's why we have ink. we like being in business because we like being creative, we like interacting with people. so you have time to focus on the things you love. ink from chase. so you can. ask me what
. >> so cvs, caremark, and cardinal health are forming a joint venture to create the largest genericrately, extending a three-year agreement, a deal for cardinal health to distribute cvs pharmaceutical products. both stocks are higher on this news sharply. so again, cah and cvs both to the upside. over to you. >> all right, dom, thank you. >>> the s&p has outperformed europe's broader markets, what does goldman sachs see in the year ahead? they offer the outlook for...